Bicyclic Peptide Ligands Specific for NECTIN-4
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application 16/446,901, filed Jun 20, 2019. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,180,531 | Bicyclic Peptide Ligands Specific for NECTIN-4 In force · High confidence | Bicycletx Limited | In force | High confidence | ||
| US 11,453,702 | Bicyclic Peptide Ligands Specific for NECTIN-4 In force · High confidence | Bicycletx Limited | In force | High confidence | ||
| US 11,912,792 | Bicyclic Peptide Ligands Specific for NECTIN-4 In force · High confidence | Bicycletx Limited | In force | High confidence | ||
| Application 18/427,414 | Bicyclic Peptide Ligands Specific for NECTIN-4 Pending Not granted | Bicycletx Limited | Pending | Not granted |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Bicycletx Limited.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.